SUDEEP PHARMA
Back to Cashflow Statement
|
SUDEEP PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹49 Cr | ₹66 Cr | ₹48 Cr | ₹-2.98 Cr | ₹35 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUDEEP PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹49 Cr |
| Mar2024 | ₹66 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹-2.98 Cr |
| Mar2021 | ₹35 Cr |
How is Cash Flow from Operating Activities of SUDEEP PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹49 Cr | -25.82 | |
| Mar2024 | ₹66 Cr | 35.73 | |
| Mar2023 | ₹48 Cr | Positive | |
| Mar2022 | ₹-2.98 Cr | Negative | |
| Mar2021 | ₹35 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,284.3 Cr | -1.1% | 22% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -1.1% |
22% |
|
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses